Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option

Cost-effectiveness analysis of rotavirus vaccination in China: Projected possibility of scale-up from the current domestic option

Abstract Background Rotavirus infection causes considerable disease burden of acute gastroenteritis (AGE) hospitalization and death among children less than 5 years in China. Although two rotavirus vaccines (Rotarix and RotaTeq) have been licensed in more than 100 countries in the world, the Lanzhou...

Full description

Bibliographic Details
Main Authors: Shuhui Cui, Ruoyan Gai Tobe, Xiuting Mo, Xiaoyan Liu, Lingzhong Xu, Shixue Li
Format: Article
Language:English
Published: BMC 2016-11-01
Series:BMC Infectious Diseases
Subjects:
Rotavirus
Vaccination
China
Cost-effectiveness
Routine immunization
Online Access:http://link.springer.com/article/10.1186/s12879-016-2013-1

Internet

http://link.springer.com/article/10.1186/s12879-016-2013-1

Similar Items